These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2845163)

  • 1. Cardiovascular effects of dibutyryl cyclic AMP in patients with congestive heart failure--comparison with dobutamine and captopril.
    Nakanishi M; Yokota Y; Fukuzaki H
    Jpn Circ J; 1988 Jun; 52(6):503-10. PubMed ID: 2845163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative hemodynamic effects of intravenous dobutamine and dibutyryl cyclic AMP, a new inotropic agent, in severe congestive heart failure.
    Miyagi Y; Sasayama S; Nakajima H; Fujita M; Asanoi H
    J Cardiovasc Pharmacol; 1990 Jan; 15(1):138-43. PubMed ID: 1688971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hemodynamic effects of dibutyryl cyclic AMP in congestive heart failure.
    Matsui S; Murakami E; Takekoshi N; Emoto J; Matoba M
    Am J Cardiol; 1983 May; 51(8):1364-8. PubMed ID: 6303101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemodynamic effects of dobutamine in patients with congestive heart failure receiving captopril.
    Ikram H; Maslowski AH; Nicholls MG
    Br Heart J; 1981 Nov; 46(5):528-30. PubMed ID: 7032556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effect of captopril and dobutamine on left ventricular pressure-volume and pressure-shortening relations in severe cardiac failure.
    Lewis BS; Halon DA; Rodeanu ME; Merdler A; Saggie Y; Hardoff R
    Int J Cardiol; 1988 Nov; 21(2):157-66. PubMed ID: 3066763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
    Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E
    Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Central and regional vascular hemodynamics of milrinone in experimental heart failure: comparison with captopril and dobutamine].
    Drexler H; Faude F; Winterer H; Wollschläger H; Freudenberg N; Just H
    Z Kardiol; 1987 Aug; 76(8):507-13. PubMed ID: 3314215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cardiovascular effects of the continuous infusion of dobutamine in patients with severe cardiac failure.
    Leier CV; Webel J; Bush CA
    Circulation; 1977 Sep; 56(3):468-72. PubMed ID: 884803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute hemodynamic and neuroendocrine effects of dopexamine, a new vasodilator for the treatment of heart failure: comparison with dobutamine, captopril, and nitrate.
    Bayliss J; Thomas L; Poole-Wilson P
    J Cardiovasc Pharmacol; 1987 May; 9(5):551-4. PubMed ID: 2439836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic response of a canine model of chronic heart failure to intravenous dobutamine, nitroprusside, enalaprilat, and digoxin.
    Sabbah HN; Levine TB; Gheorghiade M; Kono T; Goldstein S
    Cardiovasc Drugs Ther; 1993 Jun; 7(3):349-56. PubMed ID: 8395876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative hemodynamic effects of inotropic and vasodilator drugs in severe heart failure.
    Mikulic E; Cohn JN; Franciosa JA
    Circulation; 1977 Oct; 56(4 Pt 1):528-33. PubMed ID: 902377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of dobutamine, propranolol and nitroglycerin on an experimental canine model of congestive heart failure.
    Kamijo T; Tomaru T; Miwa AY; Nakamura F; Kido H; Sugimoto T; Uchida Y
    Jpn J Pharmacol; 1994 Jul; 65(3):223-31. PubMed ID: 7799523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative immediate hemodynamic and hormonal effects of amrinone and captopril in patients with severe chronic heart failure.
    Packer M; Medina N; Yushak M
    Am J Med Sci; 1986 Jan; 291(1):8-15. PubMed ID: 3510545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between plasma dobutamine concentrations and cardiovascular responses in cardiac failure.
    Leier CV; Unverferth DV; Kates RE
    Am J Med; 1979 Feb; 66(2):238-42. PubMed ID: 425967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute effects of dibutyryl cyclic AMP on renal circulation in congestive heart failure.
    Hoshino Y
    Jpn Heart J; 1988 Nov; 29(6):771-9. PubMed ID: 2853776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative differences in the hemodynamic effects of captopril and nitroprusside in severe chronic heart failure.
    Packer M; Meller J; Medina N; Yushak M
    Am J Cardiol; 1983 Jan; 51(1):183-8. PubMed ID: 6336876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemodynamic effects of dobutamine in patients with coronary artery disease.
    Magnani B; Ambrosioni E; Branzi A; Picchio F; Capitanucci P
    J Int Med Res; 1977; 5(1):10-7. PubMed ID: 838109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inotropic, vascular and neuroendocrine effects of dopexamine hydrochloride and comparison with dobutamine.
    Jaski BE; Peters C
    Am J Cardiol; 1988 Aug; 62(5):63C-67C. PubMed ID: 3407597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative haemodynamic effects of dobutamine and isoproterenol in man.
    Rigaud M; Boschat J; Rocha P; Ferreira A; Bardet J; Bourdarias JP
    Intensive Care Med; 1977 Aug; 3(2):57-62. PubMed ID: 893774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative hemodynamic effects of intravenous dobutamine and MDL-17,043, a new cardioactive drug, in severe congestive heart failure.
    Amin DK; Shah PK; Shellock FG; Hulse S; Brandon G; Spangenberg R; Swan HJ
    Am Heart J; 1985 Jan; 109(1):91-8. PubMed ID: 3155585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.